Chlamydia prevention indicators for Australia: Review of the evidence from New South Wales

Sexual Health

Volumn 9, Issue 5, 2012, Pages 399-406

  Ali, Hammad ^a   Donovan, Basil ^a,b   Liu, Bette ^a   Hocking, Jane S ^c   Agius, Paul ^d   Ward, James ^a   Bourne, Christopher ^b   Kaldor, John M ^a   Guy, Rebecca J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY EYE HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

Author keywords

epidemiology; heterosexuals; surveillance; young people

Indexed keywords

AUSTRALIA; CHLAMYDIA; CHLAMYDIASIS; DIAGNOSTIC TEST; DISEASE TRANSMISSION; HEALTH SERVICE; HEALTH SURVEY; HETEROSEXUALITY; HIGH RISK BEHAVIOR; HIGH SCHOOL; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION CONTROL; MEDICARE; PELVIC INFLAMMATORY DISEASE; PREVALENCE; REVIEW; SENTINEL SURVEILLANCE; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUAL HEALTH; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; COHORT STUDIES; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; DISEASE NOTIFICATION; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; NEW SOUTH WALES; PELVIC INFLAMMATORY DISEASE; SENTINEL SURVEILLANCE; SEX FACTORS; UNSAFE SEX; YOUNG ADULT;

EID: 84867628045     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH11183     Document Type: Review

References (38)

1. Kong F, Guy RJ, Hocking JS, Merritt T, Pirotta M, Heal C, et al. Australian general practitioner chlamydia testing rates among young people. Med J Aust 2011; 194:2 49-52.
2. Department of Health and Ageing (DOHA). National notifiable diseases surveillance system. Canberra: DOHA; 2011. Available online at: http://www9.health.gov.au/cda/source/Rpt-5-sel.cfm [verified November 2011].
3. NSW Department of Health. Chlamydia (genital only) notifications in NSW residents, 2012. Available online at: http://www.health.nsw. gov.au/data/diseases/chlamydia.asp [verified July 2012]
4. Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, TaylorRobinson D, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. Brit Med J 2010; 340: c1642. doi:10.1136/bmj.c1642
5. Falk L, Coble B, Mjornberg P, Fredlund H. Sampling for Chlamydia trachomatis infection - a comparison of vaginal, first-catch urine, combined vaginal and first-catch urine and endocervical sampling. Int J STD AIDS 2010; 21:2 83-287. doi:10.1258/ijsa.2009.009440
6. Michel C, Sonnex C, Carne C, White J, Magbanua J, Nadala E, et al. Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies. J Clin Microbiol 2007; 45: 1395. doi:10.1128/JCM.00100-07 (Pubitemid 46762389)
7. Owusu-Edusei K Jr, Bohm M, Chesson H, Kent C. Chlamydia screening and pelvic inflammatory disease: insights from exploratory time-series analyses. Am J Prev Med 2010; 38:6 52-7. doi:10.1016/j.amepre.2010.02.008
8. Idahl A, Lundin E, Elgh F, Jurstrand M, Møller J, Marklund I, et al. Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions. Am J Obs Gyn 2010; 202: 71
9. Peterman T, Gottlieb S, Berman S. Chlamydia trachomatis screening: what are we trying to do? Int J Epidemiol 2009; 38: 449. doi:10.1093/ije/dyn345
10. Harryman L, Horner P. Chlamydia trachomatis and non-gonococcal urethritis. Medicine 2010; 38:2 49-54. doi:10.1016/j.mpmed.2010. 01.003
11. Trautmann G, Kip K, Richter H, Soper D, Peipert J, Nelson D, et al. Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease? Am J Obs & Gyn 2008; 198: 30.
12. Ness R, Soper D, Richter H, Randall H, Peipert J, Nelson D, et al. Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) study. Sex Transm Dis 2008; 35: 129. doi:10.1097/OLQ.0b013e3181557c25 (Pubitemid 351158690)
13. Gray-Swain M, Peipert J. Pelvic inflammatory disease in adolescents. Curr Opin Obs Gyn 2006; 18: 503. doi:10.1097/01.gco.0000242952. 87125.69
14. Rutherford G, McFarland W, Spindler H, White K, Patel S, Aberle-Grasse J, et al. Public health triangulation: approach and application to synthesizing data to understand national and local HIV epidemics. BMC Public Health 2010; 10: 447. doi:10.1186/1471-2458-10-447
15. Joint United Nations Programme on HIV/AIDS. Implementation of the declaration of commitment on HIV/AIDS: core indicators. Geneva: United Nations General Assembly Special Session on HIV/AIDS; 2005.
16. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097. doi:10.1371/journal.pmed.1000097
17. Dicker LW, Mosure DJ, Levine WC. Chlamydia positivity versus prevalence: what's the difference? Sex Transm Dis 1998; 25: 251. doi:10.1097/00007435- 199805000-00006 (Pubitemid 28234590)
18. LaMontagne D, Fenton K, Pimenta J, Catchpole M, Rogers P, Randall S, et al. Using chlamydia positivity to estimate prevalence: evidence from the chlamydia screening pilot in England. Int J STD AIDS 2005; 16: 323. doi:10.1258/0956462053654249 (Pubitemid 40676413)
19. Smith A, Agius P, Mitchell A, Barrett C, Pitts M. Secondary students and sexual health: Results of the 4th national survey of Australian secondary students, HIV/AIDS and sexual health. Melbourne: Australian Research Centre in Sex, Health & Society, La Trobe University; 2009. Available online at: http://www.latrobe.edu.au/arcshs/downloads/arcshs-research-publications/ secondary-students-and-sexual-health-2008.pdf [verified December 2011].
20. Kirby D. Emerging answers 2007: research findings on programs to reduce teen pregnancy and sexually transmitted diseases. Washington DC: National Campaign to Prevent Teen and Unplanned Pregnancy: 2007. Available online at: http://www.thenationalcampaign.org/EA2007/EA2007-full.pdf [verified December 2011].
21. Royal Australian College of General Practitioners (RACGP). Guidelines for preventive activities in general practice, 7th edition. Melbourne: RACGP; 2009.
22. Sexual Health Society of Victoria. National management guidelines for sexually transmitted infection. 2008. Available online at: http://www.som.uq. edu.au/media/106223/sh7.pdf [verified July 2012]
23. Guy R, Ali H, Liu B, Poznanski S, Ward J, Donovan B, et al. Efficacy of interventions to increase the uptake of chlamydia testing in primary care: a systematic review. BMC Infect Dis 2011; 11: 211. doi:10.1186/1471-2334-11-211
24. Pavlin NL, Gunn JM, Parker R, Fairley CK, Hocking J. Implementing chlamydia screening: what do women think? A systematic review of the literature. BMC Public Health 2006; 6: 221. doi:10.1186/1471-2458-6-221 (Pubitemid 44401686)
25. Grulich AE, Jin J. Sex in New South Wales: a companion report to The Australian and New Zealand Journal of Public Health 2003; Volume 27, Number 2. Sydney: National Centre in HIV Epidemiology and Clinical Research; 2003.
26. Adam P, de Wit J, Hermans J, Story L, Edwards B, Murray C, et al. Understanding barriers to STI testing among young people: results from the online survey 'Getting Down To it'. Sydney: National Centre in HIV Social Research, The University of New South Wales; 2011.
27. Walker J, Fairley C, Bradshaw C, Tabrizi S, Chen M, Twin J, et al. The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women. BMC Infect Dis 2011; 11: 35. doi:10.1186/1471-2334-11-35
28. Guy R, Kong F, Goller J, Franklin N, Bergeri I, Dimech W, et al. A new national chlamydia sentinel surveillance system in Australia: evaluation of the first stage of implementation. Commun Dis Intell 2010; 34: 319
29. Vodstrcil L, Fairley C, Fehler G, Leslie D, Walker J, Bradshaw C, et al. Trends in chlamydia and gonorrhea positivity among heterosexual men and men who have sex with men attending a large urban sexual health service in Australia, 2002-2009. BMC Infect Dis 2011; 11: 158. doi:10.1186/1471-2334-11-158
30. O'Rourke KM, Fairley CK, Samaranayake A, Collignon P, Hocking JS. Trends in chlamydia positivity over time among women in Melbourne Australia, 2003 to 2007. Sex Transm Dis 2009; 36: 763. doi:10.1097/OLQ.0b013e3181b12765
31. Guy R, Wand H, Franklin N, Fairley CK, Chen MY, O'Connor CC, et al. Re-testing for chlamydia at sexual health services in Australia, 2004-08. Sex Health 2011; 8: 242. doi:10.1071/SH10086
32. Hocking J, Temple-Smith M, Poznanski S, Vaisey V, Walker J, Guy R, et al. High chlamydia prevalence among young Australian men and women: results from the Australian Chlamydia Control Effectiveness Pilot. Australian Sexual Health Conference 2011. Canberra, Australia.
33. Chen M, Fairley C, Donovan B. Discordance between trends in chlamydia notifications and hospital admission rates for chlamydia related diseases in New South Wales, Australia. Sex Transm Infect 2005; 81: 318. doi:10.1136/sti.2004. 012807 (Pubitemid 41160737)
34. Cassell J, Low N. How can chlamydia diagnoses increase when their complications are declining? Sex Transm Infect 2005; 81: 285. doi:10.1136/sti.2005.014902 (Pubitemid 41160730)
35. Department of Health and Ageing (DOHA). Third national Aboriginal and Torres Strait Islander blood borne viruses and sexually transmissible infections strategy 2010-2013. Canberra: DOHA; 2010.
36. Medicare Australia. Medicare benefits schedule (MBS) statistics, 2011. Medicare Australia; 2011. Available online at: https://www.medicareaustralia. gov.au/statistics/mbs-item.shtml [verified December 2011].
37. Australian Bureau of Statistics (ABS). Statistics 2009. Canberra: ABS; 2009. Available online at: http://www.abs.gov.au/ausstats/abs@nsf/web+pages/ statistics [verified December 2011].
38. NSW Ministry of Health. Separation statistics by principal diagnosis in ICD-10-AM, NSW, 2000 to 2010.